Loading
Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares Immunomodulatory triple-negative breast cancer (IM), Basal-like breast cancer, BRCA-associated triple-negative breast cancer, KEYNOTE-522 and the tags breast, tnbc, subtype-page.
Shares Basal-like 2 triple-negative breast cancer (BL2), Basal-like breast cancer, KEYNOTE-522, Triple-negative breast cancer (TNBC) and the tags breast, tnbc, subtype-page.
Shares Immunomodulatory triple-negative breast cancer (IM), KEYNOTE-522, Triple-negative breast cancer (TNBC), Pembrolizumab and the tags breast, tnbc, subtype-page.
Shares Luminal androgen receptor triple-negative breast cancer (LAR), Triple-negative breast cancer (TNBC) and the tags breast, tnbc, subtype-page.
Shares Basal-like breast cancer, Triple-negative breast cancer (TNBC) and the tags breast, tnbc, subtype-page.
Shares Carboplatin, Triple-negative breast cancer (TNBC), Pembrolizumab and the tags breast, tnbc, subtype-page.
Shares BRCA-associated triple-negative breast cancer, KEYNOTE-522, Pathologic complete response (pCR), Early triple-negative breast cancer and the tags breast, tnbc.
Shares Luminal androgen receptor triple-negative breast cancer (LAR), Basal-like breast cancer, Pathologic complete response (pCR), Triple-negative breast cancer (TNBC) and the tags breast, tnbc.
The same record for scripts and assistants; checked 2026-09-24. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.